With a focus on the latest clinical trial data supporting individualized treatment strategies, this accredited, on-demand activity discusses best practices for addressing unmet needs in treatment selection, sequencing, and disease monitoring in Waldenström macroglobulinemia (WM).
Learning Objectives
After participating in this activity, participants should be better able to:
Summarize strategies for addressing unmet needs in treatment selection, sequencing, and disease monitoring in WM
Appraise clinical trial data for individualized treatment strategies in WM.
On-Demand Webcast
FACULTY
Stephen M. Ansell, MD, PhD
Professor of Medicine
Mayo Clinic
Rochester, Minnesota
Jorge J. Castillo, MD
Associate Professor
Harvard Medical School
Boston, Massachusetts
Richard R. Furman, MD
Morton Coleman, MD Distinguished Professor of Medicine
Weill Cornell Medicine
New York, New York
For more information, and to participate in the webcast, please visit the following link: